Figure 8 Investment Strategies’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
20,306
+1,607
+9% +$87.1K 1.09% 40
2025
Q4
$917K Sell
18,699
-28
-0.1% -$1.31K 0.82% 45
2025
Q3
$808K Buy
18,727
+2,860
+18% +$112K 0.72% 45
2025
Q2
$609K Sell
15,867
-1,079
-6% -$41.2K 0.6% 50
2025
Q1
$656K Buy
16,946
+2,490
+17% +$91.2K 0.69% 42
2024
Q4
$489K Buy
+14,456
New +$520K 0.48% 43

Other funds holding GSK

Figure 8 Investment Strategies's GSK Position: Q1 2026 in Review

Figure 8 Investment Strategies increased its GSK (GSK) stake by 8.6% in Q1 2026, buying an estimated $87.1K and bringing the position to 20,306 shares worth $1.12M. The position accounts for 1.09% of the portfolio, ranked #40.

Figure 8 Investment Strategies first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Figure 8 Investment Strategies held 20,306 shares of GSK worth $1.12M as of Q1 2026.
  • Figure 8 Investment Strategies bought 1,607 GSK shares in Q1 2026, an estimated $87.1K.
  • GSK made up 1.09% of Figure 8 Investment Strategies's portfolio in Q1 2026, its #40 holding.
  • Figure 8 Investment Strategies first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Figure 8 Investment Strategies's 13F filing for Q1 2026, filed 23 Apr 2026.